PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Haemostasis and Thrombosis Unit, Hospital de La Santa Creu I Sant Pau. Carrer de Sant Quintí 89, 08041, Barcelona, Spain. mcorrochano@santpau.cat.\', \'Haemostasis and Thrombosis Unit, Hospital de La Santa Creu I Sant Pau. Carrer de Sant Quintí 89, 08041, Barcelona, Spain.\', \'Clinical Trials Unit (AGDAC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'Clinical Pharmacology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'ALBA Synchrotron, Barcelona, Spain.\', \'Unit of Genomics of Complex Diseases, Institut d\'Investigació Biomèdica Sant Pau, IIB-Sant Pau, Barcelona, Spain.\', \'Drug Research Center, Institut d\'Investigació Biomèdica Sant Pau, IIB-Sant Pau, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11239-021-02507-2
?:hasPublicationType
?:journal
  • Journal of thrombosis and thrombolysis
is ?:pmid of
?:pmid
?:pmid
  • 34138399
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.991
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all